<DOC>
	<DOCNO>NCT02571205</DOCNO>
	<brief_summary>`` Observational study clinical outcome testosterone treatment pubertal delay Duchenne Muscular Dystrophy '' single centre observational study aim follow progress 20 adolescent Duchenne Muscular Dystrophy ( DMD ) delay puberty treat Newcastle muscle team , treat testosterone induce puberty . The participant treat standard stepwise regimen testosterone injection every 4 week data collect help determine effectiveness tolerability current treatment regimen . The investigator use data explore effect testosterone pubertal development , growth , muscle strength function , bone mineral density body composition characterise side effect . Semi-structured interview also carry learn boy ' view tolerability regimen . The study last maximum 27 month total participant , may less happy pubertal development time . It important study investigator 's limited experience group , testosterone treatment seem well like tolerate best treatment regimen use remain unknown current consensus . It currently part standard care DMD would important include study show effective treatment pubertal delay .</brief_summary>
	<brief_title>Testosterone Therapy Pubertal Delay Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Puberty , Delayed</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>A molecular diagnosis Duchenne Muscular Dystrophy . Males age 12 17 year age time first dose Prepubertal ( Tanner stage 1 , testicular volume &lt; 4 ml , initial testosterone level &lt; 2.0 nmol/l ) Subjects receive standard care DMD recommend NorthStar UK TREATNMD guideline Patients capable sit upright wheelchair least hour Patients stable respiratory function . Artificial ventilation either Bipap/continuous positive airway pressure ( CPAP ) tracheostomy contraindication study . Informed consent/assent sign patient ( parent/guardian 16 year age ) Severe learn difficulty would preclude cooperate examination . Anticipated surgery study period . Symptomatic cardiac failure . Participants/families may emotional psychological problem recruit study Hypersensitivity active substance excipients , include arachis oil derivative ( include hypersensitivity allergy peanut soya . ) Any contraindication receive intramuscular injection Any additional chronic disease affect androgen production Anticoagulant therapy If participation study recommend opinion investigator</criteria>
	<gender>Male</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>testosterone</keyword>
	<keyword>pubertal delay</keyword>
</DOC>